Anthropic's anticipated IPO valuation of approximately $1.3 trillion sparked debate among investors on the Bits + Bips podcast. Ramit Sethi argued that the AI lab is "cheap" at that valuation, reflecting strong conviction in Anthropic's long-term growth trajectory and dominant position in enterprise AI. Austin Campbell countered with a more cautious framing, describing the IPO as "a timing play," suggesting that while Anthropic may be fundamentally sound, the entry point and market conditions will determine near-term returns. Seth Gins added perspective from the biotech-AI intersection, noting expectations that AI labs could capture revenue shares from new drug discoveries enabled by their models.